Anthropic has confidentially filed for an IPO, putting it ahead of OpenAI in the race to public markets, after last raising $65 billion at a $965 billion post-money valuation. The move could be one of the most consequential AI listings in years and may boost the long-dormant IPO market, though it could also absorb capital and attention from smaller deals. The article notes U.S. IPO proceeds reached $87.5 billion through May 26, the highest year-to-date total since 2021.
This is less about one IPO than about the sequencing of the AI capital cycle. A frontier-model listing before the market has fully absorbed the economics of training/inference should force a normalization of valuation methodology: public investors will start demanding clearer disclosure on gross margin by model family, capex intensity, and customer concentration. That creates a second-order pressure on adjacent software vendors whose multiples have been supported by “AI optionality” rather than realized monetization; the market may begin to distinguish between model owners, infrastructure enablers, and application-layer incumbents much more harshly over the next 1-2 quarters.
The most immediate winner is the private-markets complex: a marquee exit validates late-stage pricing and can briefly reopen the IPO window for sponsors and crossover funds with trapped exposure. Blackstone and other large allocators are likely to use a strong debut to mark up the rest of their AI/private-tech book, but that benefit may be temporary if the deal is too large relative to available public capital. In that case, the “liquidity tax” falls on smaller new issues first, widening discounts and forcing underwriters to reprice risk across the IPO calendar.
The key risk is not demand for the name itself, but demand exhaustion across the whole AI trade. If the deal structure implies a trillion-dollar asset while profitability remains opaque, the stock could trade well initially and still underperform after the first two quarters as investors focus on burn, dilution, and customer retention. Any disappointment in public-market disclosure cadence, or a broad drawdown in software multiples, would likely hit the inferred beneficiaries faster than the IPO itself.
The contrarian read is that going public early may be a defensive move, not an offensive one. If management believes private capital is still available but less favorable terms are coming, the IPO becomes a mechanism to lock in valuation before the market starts pricing in lower incremental ROI on AI spend. That suggests the real trade is not “buy the IPO,” but “fade the most crowded AI beneficiary basket if the listing succeeds and reallocates attention away from the infrastructure names.”
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.35
Ticker Sentiment
